# Rheumatoid Arthritis Multiomics Network Analysis

[![License: MIT](https://img.shields.io/badge/License-MIT-yellow.svg)](https://opensource.org/licenses/MIT)
[![Python 3.8+](https://img.shields.io/badge/python-3.8+-blue.svg)](https://www.python.org/downloads/)
[![Jupyter](https://img.shields.io/badge/Jupyter-Notebook-orange.svg)](https://jupyter.org/)
[![Open In Colab](https://colab.research.google.com/assets/colab-badge.svg)](https://colab.research.google.com/github/your-username/ra-multiomics-network-analysis/blob/main/notebooks/RA_Multiomics_Network_Analysis_Tutorial.ipynb)

> **Integrative computational framework for identifying biomarkers and therapeutic targets in rheumatoid arthritis through multiomics network analysis**

## 🎯 Overview

This repository provides a comprehensive tutorial and implementation of integrative multiomics network analysis for rheumatoid arthritis (RA) research. Based on the methodology from Alsaedi et al. (2024), this framework demonstrates how to combine genetic, transcriptomic, proteomic, metabolomic, and clinical data to identify potential biomarkers and therapeutic targets.

### 🔬 Key Features

- **Five-stage computational workflow** for multiomics integration
- **Synthetic RA dataset** with 200 samples across multiple omics layers
- **Network-based analysis** using protein-protein interactions
- **Therapeutic target prioritization** with evidence integration
- **Drug repurposing identification** for existing therapeutics
- **Interactive visualizations** and comprehensive documentation

## 📊 Dataset Overview

| Data Type | Samples | Features | Description |
|-----------|---------|----------|-------------|
| **Genetic Variants** | 199 variants | 120 genes | RA-associated SNPs from GWAS studies |
| **Gene Expression** | 200 samples | 121 genes | RNA-seq data (100 RA, 100 controls) |
| **Protein Abundance** | 200 samples | 121 proteins | Proteomic profiles matching expression |
| **Metabolomics** | 200 samples | 40 metabolites | Small molecule concentrations |
| **Clinical Data** | 200 samples | 15 measures | Disease activity, biomarkers, demographics |
| **Pathway Annotations** | 81 associations | 7 pathways | Functional gene groupings |

## 🚀 Quick Start

### Option 1: Google Colab (Recommended)
1. Click the "Open in Colab" badge above
2. Upload the dataset files when prompted
3. Run all cells to complete the analysis

### Option 2: Local Installation
```bash
# Clone the repository
git clone https://github.com/your-username/ra-multiomics-network-analysis.git
cd ra-multiomics-network-analysis

# Install dependencies
pip install -r requirements.txt

# Launch Jupyter Notebook
jupyter notebook notebooks/RA_Multiomics_Network_Analysis_Tutorial.ipynb
```

## 🔬 Methodology

### Five-Stage Computational Workflow

#### 🔍 **Stage 1: Data Curation and Validation**
- Quality assessment of multiomics datasets
- Sample characteristics analysis
- Data integration and harmonization

#### 🧬 **Stage 2: Genetic Enrichment Analysis**
- Gene-level variant aggregation
- Pathway enrichment testing
- Functional consequence analysis

#### 🎯 **Stage 3: Disease Mapping and Drug Target Identification**
- Differential expression analysis
- Biomarker identification
- Clinical correlation assessment

#### 🕸️ **Stage 4: Molecular Network Construction**
- Protein-protein interaction networks
- Network topology analysis
- Community detection and hub identification

#### 💊 **Stage 5: Network Pathway Analysis and Therapeutic Target Discovery**
- Integrative evidence scoring
- Drug repurposing analysis
- Final target prioritization

## 📈 Key Results

### 🏆 Top Therapeutic Targets
Our analysis identifies high-priority targets based on multiple evidence types:

1. **TNF** - Established target with multiple approved drugs
2. **IL6** - Key inflammatory mediator
3. **IL1B** - Central cytokine in RA pathogenesis
4. **STAT1/3** - JAK-STAT signaling pathway
5. **NFKB1** - Transcriptional regulator

### 💊 Drug Repurposing Opportunities
- **Anti-TNF agents**: Adalimumab, Infliximab, Etanercept
- **IL-6 inhibitors**: Tocilizumab, Sarilumab
- **JAK inhibitors**: Targeting STAT signaling
- **IL-1 antagonists**: Anakinra, Canakinumab

### 🛤️ Key Biological Pathways
- **Immune Response** (HLA genes, STAT signaling)
- **Inflammatory Response** (TNF, interleukins)
- **T Cell Activation** (CD molecules, FOXP3)
- **Bone/Cartilage Metabolism** (RANKL/OPG, MMPs)

## 📁 Repository Structure

```
ra-multiomics-network-analysis/
├── 📓 notebooks/
│   └── RA_Multiomics_Network_Analysis_Tutorial.ipynb  # Main tutorial
├── 📊 data/
│   ├── ra_genetic_variants.csv                        # Genetic variants
│   ├── ra_gene_expression.csv                         # Expression data
│   ├── ra_protein_abundance.csv                       # Protein levels
│   ├── ra_metabolomics.csv                           # Metabolite data
│   ├── ra_clinical_data.csv                          # Clinical measures
│   └── ra_pathway_annotations.csv                     # Pathway info
├── 🔧 scripts/
│   ├── create_ra_multiomics_dataset.py               # Dataset generation
│   └── network_analysis_utils.py                     # Analysis utilities
├── 📚 docs/
│   ├── methodology.md                                 # Detailed methods
│   ├── troubleshooting.md                            # Common issues
│   └── api_reference.md                              # Function documentation
├── 🖼️ images/
│   └── workflow_diagram.png                          # Analysis workflow
├── ⚙️ .github/workflows/
│   └── test.yml                                       # CI/CD pipeline
├── 📋 requirements.txt                                # Python dependencies
├── 🤝 CONTRIBUTING.md                                 # Contribution guidelines
├── ⚖️ LICENSE                                         # MIT License
└── 📖 README.md                                       # This file
```

## 🛠️ Requirements

### Python Dependencies
```
pandas>=1.3.0
numpy>=1.21.0
matplotlib>=3.4.0
seaborn>=0.11.0
plotly>=5.0.0
networkx>=2.6.0
scipy>=1.7.0
scikit-learn>=1.0.0
umap-learn>=0.5.0
jupyter>=1.0.0
```

### System Requirements
- **Python**: 3.8 or higher
- **Memory**: 4GB RAM minimum, 8GB recommended
- **Storage**: 1GB free space
- **OS**: Windows, macOS, or Linux

## 🎓 Learning Objectives

After completing this tutorial, you will be able to:

✅ **Integrate multiomics data** from genetics, transcriptomics, proteomics, and metabolomics  
✅ **Construct molecular networks** using protein-protein interactions  
✅ **Perform pathway enrichment analysis** to identify key biological processes  
✅ **Identify biomarkers and therapeutic targets** through network analysis  
✅ **Apply disease mapping** to discover drug repurposing opportunities  
✅ **Visualize complex biological networks** and multiomics results  

## 📚 Educational Use Cases

### 🎓 **Academic Courses**
- **Bioinformatics**: Network analysis and systems biology
- **Computational Biology**: Multiomics integration methods
- **Biomedical Engineering**: Disease modeling and drug discovery
- **Data Science**: Biological data analysis and visualization

### 🔬 **Research Applications**
- **Autoimmune Disease Research**: Extend to other conditions
- **Drug Discovery**: Target identification and validation
- **Personalized Medicine**: Patient stratification approaches
- **Network Medicine**: Systems-level disease understanding

## 🤝 Contributing

We welcome contributions from the community! Please see [CONTRIBUTING.md](CONTRIBUTING.md) for guidelines.

### Ways to Contribute
- 🐛 **Bug Reports**: Found an issue? Let us know!
- 💡 **Feature Requests**: Suggest new functionality
- 📖 **Documentation**: Improve tutorials and guides
- 🔬 **New Analyses**: Add additional analysis methods
- 🎨 **Visualizations**: Create better plots and figures

## 📖 Citation

If you use this tutorial or methodology in your research, please cite:

```bibtex
@article{alsaedi2024integrative,
  title={Integrative Multiomics Network Analysis of Genetic Risk Factors to Infer Biomarkers and Therapeutic Targets for Rheumatoid Arthritis},
  author={Alsaedi, Sahar Balkhair and Mineta, Katsuhiko and Tamura, Naoki and Gao, Xin and Gojobori, Takashi and Ogasawara, Masahito},
  journal={Research Square},
  year={2024},
  doi={10.21203/rs.3.rs-3607429/v1}
}
```

## 🔗 Related Resources

### 📊 **Databases**
- [STRING](https://string-db.org/) - Protein-protein interactions
- [Reactome](https://reactome.org/) - Pathway analysis
- [KEGG](https://www.genome.jp/kegg/) - Biological pathways
- [Gene Ontology](http://geneontology.org/) - Functional annotations

### 🛠️ **Tools**
- [Cytoscape](https://cytoscape.org/) - Network visualization
- [R/Bioconductor](https://bioconductor.org/) - Bioinformatics packages
- [NetworkX](https://networkx.org/) - Python network analysis
- [Plotly](https://plotly.com/) - Interactive visualizations

### 📚 **Literature**
- Network medicine in autoimmune diseases
- Multiomics integration best practices
- Drug repurposing in rheumatology
- Systems biology of rheumatoid arthritis

## 📞 Support

### 🆘 **Getting Help**
- 📖 Check the [troubleshooting guide](docs/troubleshooting.md)
- 🔍 Search existing [GitHub issues](https://github.com/your-username/ra-multiomics-network-analysis/issues)
- 💬 Start a [discussion](https://github.com/your-username/ra-multiomics-network-analysis/discussions)
- 📧 Contact: sakhaa.alsaedi@kaust.edu.sa

### 🐛 **Reporting Issues**
Please include:
- Operating system and Python version
- Complete error messages
- Steps to reproduce the problem
- Expected vs. actual behavior

## 📄 License

This project is licensed under the MIT License - see the [LICENSE](LICENSE) file for details.

## 🙏 Acknowledgments

- **Original Research**: Alsaedi et al. (2024) for the foundational methodology
- **Data Sources**: Public databases and repositories used for validation
- **Community**: Contributors and users who help improve this resource
- **Institutions**: Supporting research organizations and funding bodies

---

⭐ **Found this helpful?** Please star the repository and share with colleagues!

📢 **Stay Updated**: Watch the repository for new features and improvements

🤝 **Get Involved**: Join our community of computational biologists and data scientists

